{
  "nctId": "NCT02856698",
  "briefTitle": "MIdazolam Versus MOrphine in Acute Pulmonary Edema (MIMO Trial)",
  "officialTitle": "Study Design and Rationale of \"A Multicenter, Open-Labeled, Randomized Controlled Trial Comparing MIdazolam Versus MOrphine in Acute Pulmonary Edema\": MIMO Trial",
  "protocolDocument": {
    "nctId": "NCT02856698",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2016-07-07",
    "uploadDate": "2021-10-26T07:47",
    "size": 625190,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT02856698/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 111,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2017-04-08",
    "completionDate": "2020-12-31",
    "primaryCompletionDate": "2020-12-31",
    "firstSubmitDate": "2016-07-20",
    "firstPostDate": "2016-08-05"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Patients with acute pulmonary edema with dyspnoea and anxiety\n\nExclusion Criteria:\n\n* Patients with known severe liver disease.\n* Patients with known severe renal disease.\n* Patients with expectation of death from other illness during the course of the trial.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "In-hospital Mortality",
        "description": "In hospital mortality",
        "timeFrame": "28 days after of the hospitalization"
      }
    ],
    "secondary": [
      {
        "measure": "Number of Participants That Required Invasive Mechanical Ventilation",
        "timeFrame": "Up to 1 week"
      },
      {
        "measure": "Length of Hospital Stay",
        "description": "Length of hospital stay",
        "timeFrame": "Up to 30 days"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 34,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:29:33.317Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}